These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 12736088

  • 1. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration.
    Ogawa M, Shigeto H, Yamamoto T, Oya Y, Wada K, Nishikawa T, Kawai M.
    J Neurol Sci; 2003 Jun 15; 210(1-2):53-6. PubMed ID: 12736088
    [Abstract] [Full Text] [Related]

  • 2. The stereo-specific effect of D-serine ethylester and the D-cycloserine in ataxic mutant mice.
    Saigoh K, Matsui K, Takahashi K, Nishikawa T, Wada K.
    Brain Res; 1998 Oct 12; 808(1):42-7. PubMed ID: 9795125
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.
    Rosse RB, Fay-McCarthy M, Kendrick K, Davis RE, Deutsch SI.
    Clin Neuropharmacol; 1996 Oct 12; 19(5):444-50. PubMed ID: 8889288
    [Abstract] [Full Text] [Related]

  • 9. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
    Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT.
    Am J Psychiatry; 2007 Oct 12; 164(10):1593-602. PubMed ID: 17898352
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. D-cycloserine treatment of Alzheimer disease.
    Randolph C, Roberts JW, Tierney MC, Bravi D, Mouradian MM, Chase TN.
    Alzheimer Dis Assoc Disord; 1994 Oct 12; 8(3):198-205. PubMed ID: 7986489
    [Abstract] [Full Text] [Related]

  • 15. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW.
    Arch Gen Psychiatry; 2006 Mar 12; 63(3):298-304. PubMed ID: 16520435
    [Abstract] [Full Text] [Related]

  • 16. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
    Goff DC, Tsai G, Manoach DS, Coyle JT.
    Am J Psychiatry; 1995 Aug 12; 152(8):1213-5. PubMed ID: 7625475
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological treatments of cerebellar ataxia.
    Ogawa M.
    Cerebellum; 2004 Aug 12; 3(2):107-11. PubMed ID: 15233578
    [Abstract] [Full Text] [Related]

  • 18. A pilot study of D-cycloserine in subjects with autistic disorder.
    Posey DJ, Kem DL, Swiezy NB, Sweeten TL, Wiegand RE, McDougle CJ.
    Am J Psychiatry; 2004 Nov 12; 161(11):2115-7. PubMed ID: 15514414
    [Abstract] [Full Text] [Related]

  • 19. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
    Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL.
    Am J Psychiatry; 2008 Mar 12; 165(3):335-41; quiz 409. PubMed ID: 18245177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.